Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Cumulative effect of adoption of ASU 2020-06	Common Stock	Additional Paid-in Capital	Additional Paid-in Capital Cumulative effect of adoption of ASU 2020-06	Accumulated Deficit	Accumulated Deficit Cumulative effect of adoption of ASU 2020-06	Accumulated Other Comprehensive Income
Beginning balance (in shares) at Dec. 31, 2021			12,917,027
Beginning balance at Dec. 31, 2021	$ 671,266	$ (12,050)	$ 129	$ 982,746	$ (20,726)	$ (313,495)	$ 8,676	$ 1,886
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss)/income	53,073					53,073
Dividends	(27,112)					(27,112)
Issuance of shares due to vesting of equity awards (in shares)			60,890
Issuance of shares due to vesting of equity awards	$ 0		$ 1	(1)
Accounting Standards Update [Extensible Enumeration]	Accounting Standards Update 2020-06
Issuance of shares upon exercise of stock options (in shares)			8,077
Issuance of shares upon exercise of stock options	$ 85			85
Effect of cash flow hedges	8,681							8,681
Fees for equity offerings	201			201
Cash used to settle net share equity awards	(1,862)			(1,862)
Stock-based compensation	1,487			1,487
Ending balance (in shares) at Mar. 31, 2022			12,985,994
Ending balance at Mar. 31, 2022	693,769		$ 130	961,930		(278,858)		10,567
Beginning balance (in shares) at Dec. 31, 2021			12,917,027
Beginning balance at Dec. 31, 2021	671,266	$ (12,050)	$ 129	982,746	$ (20,726)	(313,495)	$ 8,676	1,886
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss)/income	224,743
Effect of cash flow hedges	15,405
Ending balance (in shares) at Sep. 30, 2022			13,003,516
Ending balance at Sep. 30, 2022	819,203		$ 130	964,494		(162,712)		17,291
Beginning balance (in shares) at Mar. 31, 2022			12,985,994
Beginning balance at Mar. 31, 2022	693,769		$ 130	961,930		(278,858)		10,567
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss)/income	94,453					94,453
Dividends	(26,449)					(26,449)
Issuance of shares due to vesting of equity awards (in shares)			3,187
Effect of cash flow hedges	2,170							2,170
Cash used to settle net share equity awards	(53)			(53)
Stock-based compensation	1,605			1,605
Ending balance (in shares) at Jun. 30, 2022			12,989,181
Ending balance at Jun. 30, 2022	765,495		$ 130	963,482		(210,854)		12,737
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss)/income	77,217					77,217
Dividends	(29,075)					(29,075)
Issuance of shares due to vesting of equity awards (in shares)			14,335
Effect of cash flow hedges	4,554							4,554
Cash used to settle net share equity awards	(437)			(437)
Stock-based compensation	1,449			1,449
Ending balance (in shares) at Sep. 30, 2022			13,003,516
Ending balance at Sep. 30, 2022	819,203		$ 130	964,494		(162,712)		17,291
Beginning balance (in shares) at Dec. 31, 2022			13,003,702
Beginning balance at Dec. 31, 2022	819,181		$ 130	966,058		(163,556)		16,549
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss)/income	3,202					3,202
Dividends	(8,019)					(8,019)
Issuance of shares due to vesting of equity awards (in shares)			61,358
Issuance of shares due to vesting of equity awards	0		$ 1	(1)
Effect of cash flow hedges	(2,859)							(2,859)
Cash used to settle net share equity awards	(1,651)			(1,651)
Stock-based compensation	1,855			1,855
Ending balance (in shares) at Mar. 31, 2023			13,065,060
Ending balance at Mar. 31, 2023	811,709		$ 131	966,261		(168,373)		13,690
Beginning balance (in shares) at Dec. 31, 2022			13,003,702
Beginning balance at Dec. 31, 2022	819,181		$ 130	966,058		(163,556)		16,549
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss)/income	16,077
Effect of cash flow hedges	(3,050)
Ending balance (in shares) at Sep. 30, 2023			9,319,177
Ending balance at Sep. 30, 2023	598,072		$ 93	746,898		(162,418)		13,499
Beginning balance (in shares) at Mar. 31, 2023			13,065,060
Beginning balance at Mar. 31, 2023	811,709		$ 131	966,261		(168,373)		13,690
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss)/income	18,026					18,026
Dividends	(1,350)					(1,350)
Issuance of shares due to vesting of equity awards (in shares)			26,944
Repurchase of common stock - related party (Note 6) (in shares)			(3,781,561)
Repurchase of common stock – related party (Note 6)	(222,818)		$ (38)	(222,780)
Effect of cash flow hedges	1,035							1,035
Stock-based compensation	2,155			2,155
Ending balance (in shares) at Jun. 30, 2023			9,310,443
Ending balance at Jun. 30, 2023	608,757		$ 93	745,636		(151,697)		14,725
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss)/income	(5,151)					(5,151)
Dividends	(5,570)					(5,570)
Issuance of shares due to vesting of equity awards (in shares)			8,734
Repurchase of common stock – related party (Note 6)	(71)			(71)
Effect of cash flow hedges	(1,226)							(1,226)
Cash used to settle net share equity awards	(337)			(337)
Stock-based compensation	1,670			1,670
Ending balance (in shares) at Sep. 30, 2023			9,319,177
Ending balance at Sep. 30, 2023	$ 598,072		$ 93	$ 746,898		$ (162,418)		$ 13,499